Clinical Trial Update: Fluoxetine Treatment of Depression in Down Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial sponsored by Massachusetts General Hospital evaluating fluoxetine for depression in individuals with Down syndrome has completed, and results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome
• Major Depressive Disorder

Drugs mentioned

• Fluoxetine (Fluoxetine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Down Syndrome, Depression | Phase 4 | Status: COMPLETED | Results posted: 2025-03-30